We are looking for 2–17 year olds to join a Crohn’s disease (CD) clinical trial to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Inflammatory bowel disease (including associated symptoms such as rectal bleeding, perianal fistula, abdominal pain, weight loss and/or anemia), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the GI medical research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
